Tenax Therapeutics Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Tenax Therapeutics, Inc. is a Phase 3, development-stage pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company owns global rights to develop and commercialize levosimendan, which it has prioritized in the near term. Tenax Therapeutics also may resume developing its unique oral formulation of imatinib.
No news available
Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.
